This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Alwin Kraemer: Innovator in Cancer Treatment
Introduction
Alwin Kraemer is a notable inventor based in Karlsruhe, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Kraemer holds a patent for "Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering." This invention relates to compounds of the formula (I), which are utilized in methods for treating cancer. The patent outlines the use of these compounds in the manufacture of pharmaceutical compositions aimed at treating cancer, as well as methods of treatment employing the specified compounds.
Career Highlights
Throughout his career, Alwin Kraemer has worked with prestigious institutions, including the Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts and the Deutsches Krebsforschungszentrum. His work has focused on advancing cancer research and developing effective treatment options.
Collaborations
Kraemer has collaborated with notable professionals in the field, including Mads Clausen and Thomas Ostenfeld Larsen. These collaborations have contributed to the advancement of cancer treatment methodologies.
Conclusion
Alwin Kraemer's innovative work in cancer treatment exemplifies the impact of research and development in the medical field. His contributions continue to influence the fight against cancer through the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile